Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Mar 11;119(10):165-166.
doi: 10.3238/arztebl.m2022.0154.

Post-COVID Syndrome- More Questions Than Answers

Tobias Welte  1
Affiliations
Editorial

Post-COVID Syndrome- More Questions Than Answers

Tobias Welte. Dtsch Arztebl Int. .
No abstract available

PubMed Disclaimer

Comment on

  • Persisting Symptoms After COVID-19.
    Förster C, Colombo MG, Wetzel AJ, Martus P, Joos S. Förster C, et al. Dtsch Arztebl Int. 2022 Mar 11;119(10):167-174. doi: 10.3238/arztebl.m2022.0147. Dtsch Arztebl Int. 2022. PMID: 35236547 Free PMC article.
  • The Prevalence of Persistent Symptoms After COVID-19 Disease.
    Lackermair K, Wilhelm K, William F, Grzanna N, Lehmann E, Sams L, Fichtner S, Kellnar A, Estner H. Lackermair K, et al. Dtsch Arztebl Int. 2022 Mar 11;119(10):175-176. doi: 10.3238/arztebl.m2022.0125. Dtsch Arztebl Int. 2022. PMID: 35583039 Free PMC article. No abstract available.
  • Post-Acute Sequelae of SARS-CoV-2 Infection.
    Schulz M, Mangiapane S, Scherer M, Karagiannidis C, Czihal T. Schulz M, et al. Dtsch Arztebl Int. 2022 Mar 11;119(10):177-178. doi: 10.3238/arztebl.m2022.0134. Dtsch Arztebl Int. 2022. PMID: 35583040 Free PMC article. No abstract available.

References

    1. Förster C, Colombo MG, Wetzel AJ, Martus P, Joos S. Persisting symptoms after COVID-19—prevalence and risk factors in a population-based cohort. Dtsch Arztebl Int. 2022;119:167–174. - PMC - PubMed
    1. Lackermair K, Wilhelm K, William F, et al. The prevalence of persistent symptoms after COVID-19 disease—a cross-sectional study of 896 patients treated on an outpatient basis. Dtsch Arztebl Int. 2022;119:175–176. - PMC - PubMed
    1. Schulz M, Mangiapane S, Scherer M, Karagiannidis C, Czihal T. Post-acute sequelae of SARS-CoV-2 infection—characterization of community-treated patients in a case—control study based on nationwide claims data. Dtsch Arztebl Int. 2022;119:177–178. - PMC - PubMed
    1. Wirth K, Scheibenbogen CA. Unifying hypothesis of the pathophysiology of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Recognitions from the finding of autoantibodies against ss2-adrenergic receptors. Autoimmun Rev. 2020;19 102527 Epub 2020 Apr 1. - PubMed
    1. Brown SM, Bose S, Banner-Goodspeed VB, et al. Approaches to addressing post-intensive care syndrome among intensive care unit survivors. A narrative review. Ann Am Thorac Soc. 20191;6:947–956. - PubMed